Biphenyl amide p38 kinase inhibitors 2: Optimisation and SAR

Richard M Angell1, Tony D Angell, Paul Bamborough

  • 1GlaxoSmithKline R&D, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, UK.